← Back
$NKTR All transactions

NEKTAR THERAPEUTICS

▼ SELL 10b5-1 Plan

$ Value

$7K

Shares

189

Price

$34

Filed

Sep 8

Insider

Name

Zalevsky Jonathan

Title

Chief R&D Officer

CIK

0001789857

Roles

Officer

Transaction Details

Transaction Date

2025-09-04

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

17,769

Footnotes

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. | This transaction was executed in multiple trades at prices ranging from $32.08 to $33.02 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer. | This transaction was executed in multiple trades at prices ranging from $33.08 to $34.07. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer. | This transaction was executed in multiple trades at prices ranging from $34.09 to $34.95. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer. | This transaction was executed in multiple trades at prices ranging from $35.48 to $36.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Filing Info

Accession No.

0000950170-25-113692

Form Type

4

Issuer CIK

0000906709

Zalevsky Jonathan's History

Date Ticker Type Value
2026-02-18 NKTR $13K
2026-01-20 NKTR $138K
2025-12-22 NKTR A $0
2025-12-22 NKTR A $0
2025-11-25 NKTR $63K
2025-11-21 NKTR A $0
2025-11-21 NKTR A $0
2025-09-04 NKTR $26K
2025-09-04 NKTR $15K
2025-09-04 NKTR $7K

Other Insiders at NKTR (90d)

Insider Bought Sold Last
ROBIN HOWARD W
President & CEO
$31K 2026-02-18
Zalevsky Jonathan
Chief R&D Officer
$13K 2026-02-18